A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 45/06 (2006.01) A61P 27/06 (2006.01)
Patent
CA 2721749
Disclosed herein is method of treating glaucoma or ocular hypertension comprising administering a prostaglandin agonist and a second therapeutically active agent to a mammal in need thereof, wherein said second therapeutically active agent is selected from: .beta.-Blockers, Adrenergic Agonists, non-selective adrenergic agonists, .alpha.2-selective adrenergic agonists, Carbonic Anhydrase Inhibitors, Cholinergic Agonists,direct acting cholinergic agonists, chlolinesterase inhibitors, Glutamate Antagonists, Ca2+ channel blockers, Prostamides, Prostaglandins, Cannabinoids, and combinations thereof. Compositions and medicaments containing a combination of these two active agents are also disclosed.
Cette invention concerne une méthode de traitement du glaucome ou de lhypertension oculaire comprenant ladministration dun agoniste des prostaglandines et un second agent thérapeutiquement actif chez un mammifère, ledit second agent thérapeutiquement actif étant choisi parmi les ß-bloquants, les agonistes adrénergiques, les agonistes adrénergiques non sélectifs, les agonistes adrénergiques a2-sélectifs, les inhibiteurs de lanhydrase carbonique, les agonistes cholinergiques, les agonistes cholinergiques à action directe, les inhibiteurs de cholinestérase, les agonistes du glutamate, les bloqueurs des canaux calciques, les prostamides, les prostaglandines, les cannabinoïdes et leurs associations. Linvention concerne également des compositions et des médicaments contenant une association de ces deux agents actifs.
Burk Robert M.
Donde Yariv
Holoboski Mark A.
Im Wha-Bin
Old David W.
Allergan Inc.
Gowling Lafleur Henderson Llp
LandOfFree
Combination therapy for glaucoma does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Combination therapy for glaucoma, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combination therapy for glaucoma will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1886551